The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease

by Mario Cazzola
Published 2010-08-01

Cough and asthma: the role of inhaled corticosteroids and ß2-agonists

by Mario Cazzola, Maria Gabriella Matera
Published 2008-02-01

Editorial

by Mario Cazzola
Published 2007-10-01

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone

by Mario Cazzola, Paolo Noschese, Felice Di Perna
Published 2009-04-01

From large clinical trials to management of COPD in the real world

by Mario Cazzola
Published 2009-02-01

Immunomodulatory impact of a synbiotic in Th and Th models of infection

by Mario Cazzola, Thomas A. Tompkins, Maria G. Matera
Published 2010-10-01

Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers

by Franco Pasqua, Gianluca Biscione, Girolmina Crigna, Mario Cazzola
Published 2008-08-01

Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study

by Mario Cazzola, Nhân Pham-Thi, Jean-Charles Kerihuel, Henri Durand, Serge Bohbot
Published 2010-10-01

Review: Safety of long-acting β2 -agonists in the treatment of asthma

by Mario Cazzola, Maria Gabriella Matera
Published 2007-10-01